PhaseRx IPO Info
Company Name: PhaseRx
Stock Symbol: PZRX
Exchange: NASDAQ
Status: Priced
IPO Date: 5/18/2016
IPO Price:
5.00 (
-69.00%)
Underwriters
Laidlaw & Company (UK) Ltd. and Roth Capital
Amount of Offering: N/A
Number of Shares Offered: 3.7 Mil
Shares Outstanding After Offering: N/A
Valuation: N/A
Company Description
PhaseRx is a preclinical biopharmaceutical company dedicated to developing products for the treatment of inherited enzyme deficiencies in the liver using intracellular enzyme replacement therapy (i-ERT). The Company's i-ERT approach is enabled by its proprietary Hybrid mRNA Technology™ platform. PhaseRx is headquartered in Seattle, Wash.
News Headlines
